Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 205.17 USD -3.83% Market Closed
Market Cap: 30.1B USD

Intrinsic Value

The intrinsic value of one RMD stock under the Base Case scenario is 199.2 USD. Compared to the current market price of 205.17 USD, Resmed Inc is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RMD Intrinsic Value
199.2 USD
Overvaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Resmed Inc

RMD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for RMD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A swift resolution to Philips’ recall issues could undercut ResMed’s CPAP sales momentum, eroding the market share gains it has benefited from and putting pressure on future revenue growth.

Bull Theses

ResMed’s sizable market share gains in the CPAP segment, partly due to the competitor recall, position the company for sustained growth even if demand normalizes, supported by strong brand loyalty among sleep centers and clinicians.

Show More Less
How do you feel about RMD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Resmed Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Resmed Inc

Current Assets 2.8B
Cash & Short-Term Investments 521.9m
Receivables 1B
Other Current Assets 1.3B
Non-Current Assets 4.3B
Long-Term Investments 65.7m
PP&E 671.2m
Intangibles 3.2B
Other Non-Current Assets 324.9m
Efficiency

Free Cash Flow Analysis
Resmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Resmed Inc

Revenue
4.9B USD
Cost of Revenue
-2B USD
Gross Profit
2.9B USD
Operating Expenses
-1.3B USD
Operating Income
1.6B USD
Other Expenses
-311.7m USD
Net Income
1.2B USD
Fundamental Scores

RMD Profitability Score
Profitability Due Diligence

Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Operating Income
66/100
Profitability
Score

Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

RMD Solvency Score
Solvency Due Diligence

Resmed Inc's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
90/100
Solvency
Score

Resmed Inc's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RMD Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMD is 273.86 USD with a low forecast of 196.95 USD and a high forecast of 309.75 USD.

Lowest
Price Target
196.95 USD
4% Downside
Average
Price Target
273.86 USD
33% Upside
Highest
Price Target
309.75 USD
51% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for RMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RMD Insider Trading
Buy and sell transactions by insiders

RMD News

Other Videos
What is the Intrinsic Value of one RMD stock?

The intrinsic value of one RMD stock under the Base Case scenario is 199.2 USD.

Is RMD stock undervalued or overvalued?

Compared to the current market price of 205.17 USD, Resmed Inc is Overvalued by 3%.

Back to Top